Bulletin
Investor Alert

Merck & Co. Inc.

NYS: MRK

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 26, 2021, 7:59 p.m.

MRK
/zigman2/quotes/209956077/composite

$

72.73

Change

+0.11 +0.15%

Volume

Volume 952,950

Quotes are delayed by 20 min

/zigman2/quotes/209956077/composite

Previous close

$ 74.62

$ 72.62

Change

-2.00 -2.68%

Day low

Day high

$72.54

$74.71

Open

52 week low

52 week high

$65.25

$87.80

Open

Insider Actions for Merck & Co. Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/09/2020 Kenneth C. Frazier
Chairman, President & CEO; Director
144,866   Disposition at $81.74 per share. 11,841,346
11/09/2020 Kenneth C. Frazier
Chairman, President & CEO; Director
135,134   Disposition at $81.08 per share. 10,956,664
10/30/2020 Kenneth C. Frazier
Chairman, President & CEO; Director
64,073   Gift at $0 per share. 0
10/30/2020 Frank K. Clyburn
EVP, Chief Commercial Officer
1,137   Derivative/Non-derivative trans. at $75.89 per share. 86,286
10/30/2020 Michael T. Nally
EVP, Chief Marketing Officer
995   Derivative/Non-derivative trans. at $75.89 per share. 75,510
10/30/2020 Steven C. Mizell
EVP, Chief HR Officer
2,273   Derivative/Non-derivative trans. at $75.89 per share. 172,497
10/30/2020 Frank K. Clyburn
EVP, Chief Commercial Officer
2,287   Derivative/Non-derivative trans. at $75.89 per share. 173,560
10/30/2020 Michael T. Nally
EVP, Chief Marketing Officer
2,287   Derivative/Non-derivative trans. at $75.89 per share. 173,560
10/30/2020 Steven C. Mizell
EVP, Chief HR Officer
4,574   Derivative/Non-derivative trans. at $75.89 per share. 347,120
10/05/2020 Robert M. Davis
EVP, Global Svcs & CFO
251,273   Disposition at $81.03 per share. 20,360,651
10/05/2020 Robert M. Davis
EVP, Global Svcs & CFO
251,273   Derivative/Non-derivative trans. at $0 per share. 0
09/17/2020 Kenneth C. Frazier
Chairman, President & CEO; Director
15,500   Gift at $0 per share. 0
08/25/2020 Kenneth C. Frazier
Chairman, President & CEO; Director
12,500   Gift at $0 per share. 0
08/13/2020 Sanat Chattopadhyay
Exe V-P & Pres. MMD
10,380   Disposition at $83.01 per share. 861,643
08/05/2020 Frank K. Clyburn
EVP, Chief Commercial Officer
18,876   Disposition at $81.55 per share. 1,539,337
08/05/2020 Frank K. Clyburn
EVP, Chief Commercial Officer
18,876   Derivative/Non-derivative trans. at $0 per share. 0
07/17/2020 Julie Louise Gerberding
EVP Strat Comm, GI Pub Policy
18,174   Disposition at $80.01 per share. 1,454,101
07/17/2020 Julie Louise Gerberding
EVP Strat Comm, GI Pub Policy
18,111   Disposition at $80 per share. 1,448,880
07/17/2020 Julie Louise Gerberding
EVP Strat Comm, GI Pub Policy
18,111   Derivative/Non-derivative trans. at $0 per share. 0
05/07/2020 Leslie A. Brun
Director
5,000   Disposition at $75.46 per share. 377,300
05/07/2020 Wendell P. Weeks
Director
5,000   Disposition at $76.02 per share. 380,100
05/07/2020 Leslie A. Brun
Director
5,000   Derivative/Non-derivative trans. at $0 per share. 0
05/07/2020 Wendell P. Weeks
Director
5,000   Derivative/Non-derivative trans. at $0 per share. 0
05/05/2020 Frank K. Clyburn
EVP, Chief Commercial Officer
1,848   Derivative/Non-derivative trans. at $76.86 per share. 142,037
05/05/2020 Rita A. Karachun
Sr. VP Fince-Global Controller
1,617   Derivative/Non-derivative trans. at $76.86 per share. 124,282
05/05/2020 Michael T. Nally
EVP, Chief Marketing Officer
1,020   Derivative/Non-derivative trans. at $76.86 per share. 78,397
05/05/2020 Michael Fleming
SVP Chief Ethics & Com Officer
458   Derivative/Non-derivative trans. at $76.86 per share. 35,201
05/05/2020 Frank K. Clyburn
EVP, Chief Commercial Officer
3,752   Derivative/Non-derivative trans. at $76.86 per share. 288,378
05/05/2020 Rita A. Karachun
Sr. VP Fince-Global Controller
3,283   Derivative/Non-derivative trans. at $76.86 per share. 252,331
05/05/2020 Michael T. Nally
EVP, Chief Marketing Officer
2,345   Derivative/Non-derivative trans. at $76.86 per share. 180,236
05/05/2020 Michael Fleming
SVP Chief Ethics & Com Officer
1,290   Derivative/Non-derivative trans. at $76.86 per share. 99,149

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
4 Purchases
8 Sales
260,421
615,251
Last 12 months
19 Purchases
26 Sales
331,372
714,376

Officers and Executives

Mr. Kenneth C. Frazier
Chairman, President & Chief Executive Officer
Mr. Robert M. Davis
CFO & Executive Vice President-Global Services
Ms. Sandy Tremps
Vice President-R&D IT CIO
Dr. Chia Lin Wang
CEO-Development Centre
Mr. Sanat Chattopadhyay
EVP & President-Merck Manufacturing Division
Dr. John H. Markels
President-Global Vaccines
Dr. Dean Y. Li
Executive Vice President
Mr. Richard R. DeLuca
Executive Vice President & President-Animal Health
Mr. Frank K. Clyburn
Chief Commercial Officer & Executive VP
Dr. Eric Rubin
VP-Global Clinical Oncology
Dr. Luciano Rossetti
SVP-Global Scientific Strategy
Ms. Denise Williams
Vice President
Mr. Mark Talens
Executive Director-Supply Chain Execution
Mr. Sahm Nasseri
Director-Global Strategy & Marketing
Mr. Michael T. Nally
Chief Marketing Officer & Executive Vice President
Ms. Rita A. Karachun
Senior Vice President-Finance & Global Controller
Mr. Peter Dannenbaum
Vice President-Investor Relations
Mr. Steven C. Mizell
Chief Human Resources Officer & EVP-Human Resource
Ms. Jennifer Zachary
Secretary, Executive VP & General Counsel
Dr. Julie Louise Gerberding
Chief Patient Officer & EVP-Communication
Ms. Kathy J. Warden
Independent Director
Dr. Christine E. Seidman
Independent Director
Dr. Risa J. Lavizzo-Mourey
Independent Director
Mr. Thomas Henry Glocer
Independent Director
Mr. Leslie A. Brun
Lead Independent Director
Ms. Patricia Fiorello Russo
Independent Director
Mr. Peter C. Wendell
Independent Director
Dr. Thomas Robert Cech
Independent Director
Ms. Pamela J. Craig
Independent Director
Dr. Paul B. Rothman
Independent Director
Mr. Inge G. Thulin
Independent Director
Ms. Mary Ellen Coe
Independent Director
Link to MarketWatch's Slice.